Financial Gravity Companies »

Regeneron Pharmaceuticals shares owned by Financial Gravity Companies

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Financial Gravity Companies from 13F filings

Historical chart of Financial Gravity Companies investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Financial Gravity Companies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Financial Gravity Companies

Quarter filed Position value Share count Share price at filing
2018-12-31 $283k 657 430.75
2018-03-31 $211k 714 295.52
2017-12-31 $78k 212 367.92

More positions owned by Financial Gravity Companies

SPDR S&P MidCap 400 ETF (MDY)
Vanguard Total Bond Market ETF (BND)
Vanguard REIT ETF (VNQ)
Spdr Ser Tr 1 3 hgh yield (BIL)
iShares Barclays 20+ Yr Treas.Bond (TLT)
Schwab Strategic Tr sht tm us tres (SCHO)
iShares iBoxx $ High Yid Corp Bond (HYG)
Spdr Short-term High Yield mf (SJNK)
iShares IBoxx $ Invest Grade Corp Bd (LQD)
Vanguard Intermediate-Term Bond ETF (BIV)
Sherwin-Williams Company (SHW)
Global X Etf equity
iShares Lehman 7-10 Yr Treas. Bond (IEF)
SPDR Barclays Capital Intl Tresy Bd ETF (BWX)
Invesco Emerging Markets S etf (PCY)

View all positions for Financial Gravity Companies

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals